Discovering, developing and advancing diagnosis, new medicines and treatments for patients

The Leicester Precision Medicine Institute (LPMI) brings together the research expertise and facilities of the University of Leicester and University Hospitals Leicester NHS Trust with industry to advance new medicines and medical technology innovations to impact on healthcare in our multi-ethnic population.

Integration of new technologies is providing much more information about health and disease that we are using to better predict, diagnose and treat disease. Through LPMI partners we are ensuring more rapid delivery of improved healthcare to our patients in the UHL NHS trust, the wider UK and the world.

What is precision medicine?

What is precision medicine

How we deliver Precision Medicine

At the Leicester Precision Medicine Institute (LPMI) we partner with industry and local healthcare trusts to accelerate research to deliver improved treatments for patients.

The LPMI develops international links, especially those of relevance to the ethnicity and health of Leicester city residents.

Roadmap wheel

 

Leicester Precision Medicine Institute Team

Share this page:

News

UoL Professor Tim Coats was among the speakers at the opening of  NTT DATA UK’s new London office. Read more here

You can read the latest newsletter from Hope here

Dedicated Research Space for HDR-UK Midlands in Leicester is now located on the second floor of the Adrian Building. Read more here

Two Leicester professors join prestigious Academy of Medical Sciences Fellowship Read more here

The Leicester Institute for Advanced Studies (LIAS) is pleased to announce that the next call for Networks and Tiger Teams is now live. Read more here

Head of Human Genetics at Welcome Sanger Institute is elected Fellow of the Royal Society Read more here

University of Leicester to develop a new mobile application that uses data from Earth Observation satellites Read more here

Breast cancer relapse could be found two years earlier Read more here and here

Chemotherapy-free treatment gives hope to adult leukaemia patients Read more here

UoL academics named in national top 30 Read more here

Collaborative Award in Science. Read more here

New clues about why non-smokers, as well as smokers, develop chronic lung disease revealed Read more here

University of Leicester receives share of £34m BHF investment to help safeguard UK’s world-class research status Read more here

Call for abstracts in the areas of Cancer, Diabetes, Respiratory Sciences - Midlands AMS Research Festival 2019 Read more here

View slides from the LPMI August 18 Exec meeting. Read more here

More LPMI News Here

 

For LPMI Enquiries:

Professor Jacqui Shaw

Dr Ruth Barber

Dr Carl Edwards

e: LPMI@le.ac.uk

t: +44 (0)116 223 1594

Leicester Drug Discovery and Diagnostics

LD3 logo

LD3 Office:

+44 (0)116 252 3342

Email: drugdiscovery@le.ac.uk